Clinical approach to cutaneous vasculitis

Purpose of reviewThis review provides the readers with an update on the clinical approach of a patient seeking treatment with cutaneous vasculitis. It outlines the work-up for assessing patients with cutaneous vasculitis and discusses the essential features of the main conditions included within this category. Recent findingsRecent works on genetic and infectious factors implicated in the pathogenesis of Henoch-Schönlein purpura are discussed. Special attention is given to the prognosis and response to treatment. Also, recent reports on cutaneous vasculitis secondary to connective tissue diseases are reviewed. SummaryWith this review, the reader will be able to establish the steps to be followed in the clinical approach to a patient seeking treatment with cutaneous vasculitis.

[1]  C. Ferri,et al.  Cryoglobulinemic vasculitis , 2006, Current opinion in rheumatology.

[2]  T. Klassen,et al.  A randomized, placebo-controlled trial of prednisone in early Henoch Schönlein Purpura [ISRCTN85109383] , 2004, BMC medicine.

[3]  R. Weenig,et al.  Primary cutaneous small vessel vasculitis , 2004, Current treatment options in cardiovascular medicine.

[4]  J. Anaya,et al.  Cutaneous Vasculitis in Primary Sjögren Syndrome: Classification and Clinical Significance of 52 Patients , 2004, Medicine.

[5]  N. Çakır,et al.  Henoch-Schönlein purpura in two brothers imprisoned in the same jail: presentation two months apart. , 2004, Clinical and experimental rheumatology.

[6]  W. Ollier,et al.  Interleukin 1beta gene polymorphism association with severe renal manifestations and renal sequelae in Henoch-Schönlein purpura. , 2004, The Journal of rheumatology.

[7]  W. Ollier,et al.  Lack of association between endothelial nitric oxide synthase polymorphisms and Henoch-Schönlein purpura. , 2004, Journal of Rheumatology.

[8]  P. Rubegni,et al.  Sjögren's syndrome: a retrospective review of the cutaneous features of 93 patients by the Italian Group of Immunodermatology. , 2004, Clinical and experimental rheumatology.

[9]  N. Gandhi,et al.  Cutaneous vasculitis secondary to ramipril. , 2004, Journal of drugs in dermatology : JDD.

[10]  F. Kerdel,et al.  Hypocomplementemic urticarial vasculitis with angioedema, a rare presentation of systemic lupus erythematosus: rapid response to rituximab. , 2003, Journal of the American Academy of Dermatology.

[11]  Susan Ballinger.  Henoch–Schonlein purpura , 2003, Current opinion in rheumatology.

[12]  Y. Kawasaki,et al.  Clinical and pathological features of children with Henoch-Schoenlein purpura nephritis: risk factors associated with poor prognosis. , 2003, Clinical nephrology.

[13]  S. Sipka,et al.  Elevated Levels of Anti-Helicobacter pylori Antibodies in Henoch–Schönlein Purpura , 2003, Autoimmunity.

[14]  K. Nakanishi,et al.  Group A streptococcal antigen in the glomeruli of children with Henoch-Schönlein nephritis. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[15]  D. Fiorentino,et al.  Cutaneous vasculitis , 1996 .

[16]  C. Edelmann,et al.  Henoch-Schönlein purpura nephritis: course of disease and efficacy of cyclophosphamide , 2003, Pediatric Nephrology.

[17]  M. González-Gay,et al.  Henoch-Schönlein purpura in children and adults: clinical differences in a defined population. , 2002, Seminars in arthritis and rheumatism.

[18]  M. González‐Gay,et al.  Orlistat-induced cutaneous leukocytoclastic vasculitis. , 2002, Arthritis and rheumatism.

[19]  J. Stone,et al.  “Essential” cutaneous vasculitis: what every rheumatologist should know about vasculitis of the skin , 2001, Current opinion in rheumatology.

[20]  M. Gonzalez-gay,et al.  Hypersensitivity vasculitis in adults: a benign disease usually limited to skin. , 2001, Clinical and experimental rheumatology.

[21]  G. Hunder,et al.  Cutaneous vasculitis and cancer: a clinical approach. , 2000, Clinical and experimental rheumatology.

[22]  M. Gonzalez-gay,et al.  Drug associated cutaneous vasculitis in adults in northwestern Spain. , 1999, The Journal of rheumatology.

[23]  M. Gonzalez-gay,et al.  Bacterial infection presenting as cutaneous vasculitis in adults. , 1999, Clinical and experimental rheumatology.

[24]  V. Agnello.  Mixed cryoglobulinaemia after hepatitis C virus: more and less ambiguity , 1998, Annals of the rheumatic diseases.

[25]  M. Gonzalez-gay,et al.  Cutaneous vasculitis as a paraneoplastic syndrome in adults. , 1998, Arthritis and rheumatism.

[26]  R. Porter.  Nomenclature of Systemic Vasculitides: Proposal of an International Consensus Conference , 1995 .

[27]  J. Lie.  Nomenclature and classification of vasculitis: plus ça change, plus c'est la même chose. , 1994, Arthritis and rheumatism.

[28]  R J Falk,et al.  Nomenclature of systemic vasculitides. Proposal of an international consensus conference. , 1994, Arthritis and rheumatism.

[29]  D. Mehregan,et al.  Urticarial vasculitis: a histopathologic and clinical review of 72 cases. , 1992, Journal of the American Academy of Dermatology.

[30]  J. Lie.  Illustrated histopathologic classification criteria for selected vasculitis syndromes. American College of Rheumatology Subcommittee on Classification of Vasculitis. , 2010, Arthritis and rheumatism.